hepagamb.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# vestacp autogenerated robots.txt User-agent: * Crawl-delay: | ||
Meta Tags
| Title | Select a dynamic defense against reinfection and provide post-exposure |
| Description | Indications and Important Safety Information for HepaGam HepaGam B® is a HBIg approved by the FDA to prevent HBV recurrence following liver transplantation and provide post-exposure |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 54.242.137.42 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
hepagamb.com Valuation
|
US$1,568,120
Last updated: 2023-05-14 21:32:09
hepagamb.com has Semrush global rank of 6,749,677. hepagamb.com has an estimated worth of US$ 1,568,120, based on its estimated Ads revenue. hepagamb.com receives approximately 180,937 unique visitors each day. Its web server is located in United States, with IP address 54.242.137.42. According to SiteAdvisor, hepagamb.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,568,120 |
| Daily Ads Revenue | US$1,448 |
| Monthly Ads Revenue | US$43,425 |
| Yearly Ads Revenue | US$521,099 |
| Daily Unique Visitors | 12,063 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| hepagamb.com. | A | 599 | IP: 54.242.137.42 |
| hepagamb.com. | NS | 3600 | NS Record: ns72.domaincontrol.com. |
| hepagamb.com. | NS | 3600 | NS Record: ns71.domaincontrol.com. |
HtmlToTextCheckTime:2023-05-14 21:32:09
| I am a healthcare professional in: United States Canada « Previous page | Next page » --> Expand + --> Indications and Important Safety Information for HepaGam B ® Indications HepaGam B ® [Hepatitis B Immune Globulin Intravenous (Human)] is an intravenous immune globulin indicated for the following: Prevention of Hepatitis B recurrence following liver transplant in HBsAg-positive liver transplant patients Post-exposure prophylaxis including: Acute exposure to HBsAg-positive blood, plasma, or serum (parenteral exposure, direct mucus membrane contact, oral ingestion, etc.), Perinatal exposure of infants born to HBsAg-positive mothers, Sexual exposure to HBsAg-positive persons, and Household exposure to persons with acute HBV infection. Important Safety Information CONTRAINDICATIONS: Individuals known to have severe, potentially life-threatening reaction to human globulin preparations should not receive HepaGam B ® or any other immune globulin (human). Individuals who |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: nginx/1.15.8 Date: Fri, 24 Dec 2021 01:46:55 GMT Content-Type: text/html Content-Length: 169 Connection: keep-alive Location: https://hepagamb.com/ HTTP/2 200 server: nginx/1.15.8 date: Fri, 24 Dec 2021 01:46:56 GMT content-type: text/html; charset=UTF-8 vary: Accept-Encoding x-frame-options: SAMEORIGIN x-xss-protection: 1; mode=block x-content-type-options: nosniff |
hepagamb.com Whois Information
Domain Name: HEPAGAMB.COM Registry Domain ID: 346990668_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-02-16T18:31:08Z Creation Date: 2006-02-15T22:06:20Z Registry Expiry Date: 2022-02-15T22:06:20Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS71.DOMAINCONTROL.COM Name Server: NS72.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-27T07:01:37Z <<< |